BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37036419)

  • 1. Molecular Pathology of Micropapillary Carcinomas: Is Characteristic Morphology Related to Molecular Mechanisms?
    Sagnak Yilmaz Z; Sarioglu S
    Appl Immunohistochem Mol Morphol; 2023 May-Jun 01; 31(5):267-277. PubMed ID: 37036419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polarity gene alterations in pure invasive micropapillary carcinomas of the breast.
    Gruel N; Benhamo V; Bhalshankar J; Popova T; Fréneaux P; Arnould L; Mariani O; Stern MH; Raynal V; Sastre-Garau X; Rouzier R; Delattre O; Vincent-Salomon A
    Breast Cancer Res; 2014 May; 16(3):R46. PubMed ID: 24887297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PIK3CA-AKT pathway mutations in micropapillary breast carcinoma.
    Flatley E; Ang D; Warrick A; Beadling C; Corless CL; Troxell ML
    Hum Pathol; 2013 Jul; 44(7):1320-7. PubMed ID: 23352210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between lymph node metastasis and pathologic features of invasive micropapillary carcinoma of breast].
    Guo XJ; Chen L; Lang RG; Fan Y; Fu L
    Zhonghua Bing Li Xue Za Zhi; 2006 Jan; 35(1):8-12. PubMed ID: 16608641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive Micropapillary Carcinoma of the Breast: An Update.
    Yang YL; Liu BB; Zhang X; Fu L
    Arch Pathol Lab Med; 2016 Aug; 140(8):799-805. PubMed ID: 27472238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Micropapillary variant of mucinous carcinoma of the breast shows genetic alterations intermediate between those of mucinous carcinoma and micropapillary carcinoma.
    Pareja F; Selenica P; Brown DN; Sebastiao APM; da Silva EM; Da Cruz Paula A; Del A; Fu L; Weigelt B; Brogi E; Reis-Filho JS; Wen HY
    Histopathology; 2019 Jul; 75(1):139-145. PubMed ID: 30843622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive ductal carcinomas of the breast showing partial reversed cell polarity are associated with lymphatic tumor spread and may represent part of a spectrum of invasive micropapillary carcinoma.
    Acs G; Esposito NN; Rakosy Z; Laronga C; Zhang PJ
    Am J Surg Pathol; 2010 Nov; 34(11):1637-46. PubMed ID: 20975342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The investigation of transcriptional repression mediated by ZEB2 in canine invasive micropapillary carcinoma in mammary gland.
    Gamba CO; Damasceno KA; Ferreira IC; Rodrigues MA; Gomes DA; Alves MR; Rocha RM; Lima AE; Ferreira E; Cassali GD
    PLoS One; 2019; 14(1):e0209497. PubMed ID: 30645591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell polarity and cell adhesion associated gene expression differences between invasive micropapillary and no special type breast carcinomas and their prognostic significance.
    Kramer Z; Kenessey I; Gángó A; Lendvai G; Kulka J; Tőkés AM
    Sci Rep; 2021 Sep; 11(1):18484. PubMed ID: 34531452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LIN7A is a major determinant of cell-polarity defects in breast carcinomas.
    Gruel N; Fuhrmann L; Lodillinsky C; Benhamo V; Mariani O; Cédenot A; Arnould L; Macgrogan G; Sastre-Garau X; Chavrier P; Delattre O; Vincent-Salomon A
    Breast Cancer Res; 2016 Feb; 18(1):23. PubMed ID: 26887652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD1d- and PJA2-related immune microenvironment differs between invasive breast carcinomas with and without a micropapillary feature.
    Kanomata N; Kurebayashi J; Koike Y; Yamaguchi R; Moriya T
    BMC Cancer; 2019 Jan; 19(1):76. PubMed ID: 30651076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of β1 integrin contributes to polarity reversal and a poor prognosis of breast invasive micropapillary carcinoma.
    Liu B; Zheng X; Meng F; Han Y; Song Y; Liu F; Li S; Zhang L; Gu F; Zhang X; Fu L
    Oncotarget; 2018 Jan; 9(4):4338-4353. PubMed ID: 29435106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristic morphology of invasive micropapillary carcinoma of the breast: an immunohistochemical analysis.
    Yamaguchi R; Tanaka M; Kondo K; Yokoyama T; Kaneko Y; Yamaguchi M; Ogata Y; Nakashima O; Kage M; Yano H
    Jpn J Clin Oncol; 2010 Aug; 40(8):781-7. PubMed ID: 20444748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytologic findings in infiltrating micropapillary carcinoma and mucinous carcinomas with micropapillary pattern.
    Madur B; Shet T; Chinoy R
    Acta Cytol; 2007; 51(1):25-32. PubMed ID: 17328491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical analyses of CD44 variant isoforms in invasive micropapillary carcinoma of the breast: comparison with a concurrent conventional invasive carcinoma of no special type component.
    Umeda T; Ishida M; Murata S; Mori T; Kawai Y; Itoi N; Tomida K; Tanaka A; Sakai S; Kitamura M; Kubota Y; Kushima R; Tani M
    Breast Cancer; 2016 Nov; 23(6):869-875. PubMed ID: 26494575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of Leucine Zipper Putative Tumor Suppressor 1 (LZTS1) Expression Contributes to Lymph Node Metastasis of Breast Invasive Micropapillary Carcinoma.
    Wang XX; Liu BB; Wu X; Su D; Zhu Z; Fu L
    Pathol Oncol Res; 2015 Sep; 21(4):1021-6. PubMed ID: 25813822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Relationship Between E-Cadherin and its Transcriptional Repressors in Spontaneously Arising Canine Invasive Micropapillary Mammary Carcinoma.
    Gamba CO; Rodrigues MA; Gomes DA; Estrela-Lima A; Ferreira E; Cassali GD
    J Comp Pathol; 2015 Nov; 153(4):256-65. PubMed ID: 26385325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Expression of LEF1 and β-Catenin in Invasive Micropapillary Carcinoma of the Breast is Associated With Lymphovascular Invasion and Lymph Node Metastasis.
    Dolezal D; Zhang X; Harigopal M
    Appl Immunohistochem Mol Morphol; 2022 Sep; 30(8):557-565. PubMed ID: 35960138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed micropapillary-ductal carcinomas of the breast: a genomic and immunohistochemical analysis of morphologically distinct components.
    Marchiò C; Iravani M; Natrajan R; Lambros MB; Geyer FC; Savage K; Parry S; Tamber N; Fenwick K; Mackay A; Schmitt FC; Bussolati G; Ellis I; Ashworth A; Sapino A; Reis-Filho JS
    J Pathol; 2009 Jul; 218(3):301-15. PubMed ID: 19479727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucinous micropapillary carcinoma of the breast: an aggressive counterpart to conventional pure mucinous tumors.
    Barbashina V; Corben AD; Akram M; Vallejo C; Tan LK
    Hum Pathol; 2013 Aug; 44(8):1577-85. PubMed ID: 23517923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.